Product Information
SUMATRIPTAN 6 MG/0.5 ML VIAL is a generic product labeled by Caplin Steriles Limited, priced at $14.9345 per ML under NDC 65145011805. Its NADAC has been published 80 times since Mar 26, 2025.
FDA first approved this application on Jul 13, 2021. Its Orange Book therapeutic-equivalence code is AP.
Strength
6 mg/.5mL
Manufacturer
Caplin Steriles LimitedNDC
65145011805
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
SUMATRIPTAN SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA213998FDA Approved
7/13/2021
TE Code
AP
On Market Since
9/28/2024
Pharmacological Classes
Price Statistics
The NADAC for SUMATRIPTAN 6 MG/0.5 ML VIAL has been published 80 times since Mar 26, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $14.9345 per ML |
|---|---|
| All-time high | $16.1059 (Jul 16, 2025) |
| All-time low | $13.7735 (Oct 22, 2025) |
| 52-week high | $15.2668 |
| 52-week low | $13.7735 |
| Median price | $14.9345 |
| Average price | $14.9558 |
| Largest weekly change | -5.8% (Sep 17, 2025) |
| Weeks tracked | 80 |
| Tracking since | Mar 26, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Caplin Steriles Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Sumatriptan market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-1b and Serotonin-1d Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SUMATRIPTAN 6 MG/0.5 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for SUMATRIPTAN 6 MG/0.5 ML VIAL, manufactured by Caplin Steriles Limited, is $14.9345 per ML (NDC 65145011805), effective Sep 30, 2026.
How has the price of SUMATRIPTAN 6 MG/0.5 ML VIAL changed over time?
Over the history we have for it, the NADAC for SUMATRIPTAN 6 MG/0.5 ML VIAL has held within roughly two percent of its current level. It has been tracked across 80 weekly CMS publications since Mar 26, 2025.
What are the highest and lowest recorded NADAC prices for SUMATRIPTAN 6 MG/0.5 ML VIAL?
Since Mar 26, 2025, the NADAC for SUMATRIPTAN 6 MG/0.5 ML VIAL has ranged from a low of $13.7735 (Oct 22, 2025) to a high of $16.1059 (Jul 16, 2025), with a median of $14.9345 per ML.
Are there cheaper alternatives to SUMATRIPTAN 6 MG/0.5 ML VIAL?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SUMATRIPTAN 6 MG/0.5 ML VIAL, is $14.5436 per ML — about 3% below SUMATRIPTAN 6 MG/0.5 ML VIAL.
Who manufactures SUMATRIPTAN 6 MG/0.5 ML VIAL?
SUMATRIPTAN 6 MG/0.5 ML VIAL (NDC 65145011805) is labeled by Caplin Steriles Limited, and CMS classifies it as a generic product.